Table 1 Fluorescence intensity determination using Fiji software for the many cells in each patient group (from IF study).

From: Impact of prophylactic hydroxychloroquine on ultrastructural impairment and cellular SARS-CoV-2 infection in different cells of bronchoalveolar lavage fluids of COVID-19 patients

Type of cells

Patient group

Fluor. intensity mean ± SD

No of cells analyzed

Ciliated epithelium

A

17.71 ± 4.10

12

B

22.02 ± 5.32

10

C

12.17 ± 2.69

14

Type II pneumocytes

A

19.53 ± 3.67

18

B

19.99 ± 2.49

10

C

11.73 ± 1.73

09

Macrophages

A

14.47 ± 3.30

17

B

15.29 ± 2.50

11

C

15.33 ± 2.39

08

Neutrophils

A

15.55 ± 3.73

14

B

15.51 ± 2.73

13

C

15.41 ± 2.83

09

Anucleated granulocytes

A

23.74 ± 3.09

07

B

23.79 ± 3.07

04

C

23.49 ± 3.06

05

Back to article page